Bloomberg Cites PHE Alzheimer’s Disease Study
A new PHE study, commissioned by the Alzheimer’s Association, investigates the potential savings of obtaining an earlier diagnosis. As reported in Bloomberg, PHE’s study demonstrated that an increase in early diagnosis of Alzheimer’s would lead to significant savings for the US—potentially up to $7.9 trillion over the lifetimes of everyone alive right now.
To read the details in Bloomberg, please click here.
The ISPOR 23rd Annual International Meeting in Baltimore, Maryland, on May 19-23 is almost here, and Precision Health Economics (PHE) and Precision Xtract will be there ready to meet with you and share our expertise.